Table 2:
Proportion of Participants Completing ≥1 Visit During the 6.5-Month Periods before and during the pandemic stratified by patient characteristics and unadjusted risk ratios for visit completion, Johns Hopkins HIV Clinical Cohort
| 6.5 Mo. Pre-Pandemic | 6.5 Mo. During Pandemic | p-value1 | |||
|---|---|---|---|---|---|
| All Participants | 88% (1773/2010) | 91% (1753/1929) | 0.0082 | ||
| Age Category | |||||
| 20–39 | 82% | - | 92% | - | - |
| 40–59 | 87% | 1.06 (1.00, 1.13) | 90% | 0.98 (0.94, 1.02) | 0.032 |
| 60+ | 93% | 1.14 (1.07. 1.20) | 92% | 1.00 (0.96, 1.05) | 0.001 |
| Female | 86% | - | 93% | - | - |
| Male | 90% | 1.05 (1.01, 1.08) | 90% | 0.97 (0.94, 1.00) | 0.001 |
| Race | |||||
| White | 90% | - | 88% | - | - |
| Black | 88% | 0.98 (0.94, 1.02) | 91% | 1.03 (0.99, 1.08) | 0.07 |
| Other | 89% | 0.99 (0.91, 1.08) | 94% | 1.06 (0.99, 1.13) | 0.22 |
| Not Hispanic | 88% | - | 91% | - | |
| Hispanic | 87% | 0.98 (0.88, 1.09) | 94% | 1.04 (0.97, 1.11) | 0.35 |
| HIV Risk Factor | |||||
| Not MSM | 87% | - | 92% | - | |
| MSM | 90% | 1.03 (1.00, 1.07) | 89% | 0.97 (0.94, 1.01) | 0.009 |
| Not IDU | 89% | - | 91% | - | |
| IDU | 86% | 0.97 (0.93, 1.01) | 91% | 1.00 (0.97, 1.04) | 0.19 |
| No High-risk Heterosexual Contact | 89% | - | 90% | - | |
| High-risk Heterosexual Contact | 88% | 0.98 (0.95, 1.01) | 92% | 1.02 (0.99, 1.05) | 0.11 |
| Viral Suppression | |||||
| Not Virally Suppressed | 77% | - | 85% | - | |
| Virally Suppressed | 90% | 1.17 (1.07, 1.28) | 92% | 1.07 (0.99, 1.16) | 0.14 |
| No viral load in the past year | 82% | 1.07 (0.95, 1.20) | 87% | 1.02 (0.93, 1.13) | 0.59 |
| Duration of Care at JHHCC | |||||
| < 1 year | 84% | - | 89% | - | |
| 1–5 years | 85% | 1.02 (0.91, 1.13) | 90% | 1.01 (0.93, 1.11) | 0.95 |
| 6–10 years | 83% | 0.99 (0.89, 1.11) | 90% | 1.01 (0.93, 1.11) | 0.80 |
| 10+ years | 91% | 1.08 (0.98, 1.19) | 92% | 1.03 (0.95, 1.12) | 0.50 |
| No History of Depression | 89% | - | 91% | - | |
| History of Depression | 87% | 0.97 (0.94, 1.01) | 91% | 0.99 (0.97, 1.02) | 0.89 |
| No Recent Heroin Use | 89% | - | 91% | - | |
| Recent Heroin Use | 80% | 0.90 (0.80, 1.01) | 79% | 0.87 (0.77, 0.98) | 0.62 |
| No Recent Cocaine Use | 89% | - | 91% | - | |
| Recent Cocaine Use | 84% | 0.94 (0.87, 1.02) | 87% | 0.95 (0.89, 1.02) | 0.89 |
| No Recent Hazardous ETOH Use | 88% | - | 91% | - | |
| Recent Hazardous ETOH Use | 88% | 1.00 (0.94, 1.06) | 92% | 1.01 (0.96, 1.06) | 0.82 |
| No Recent Smoking | 90% | - | 91% | - | |
| Recent Smoking | 85% | 0.95 (0.92, 0.99) | 90% | 0.98 (0.95, 1.02) | 0.16 |
1
p-value for interaction between patient characteristic and time period
2
p-value for the unadjusted effect of the pandemic on visit completion